Zobrazeno 1 - 10
of 53
pro vyhledávání: '"Carlos Cuesta"'
Publikováno v:
Automatika, Vol 63, Iss 1, Pp 16-25 (2022)
This paper presents a methodology for state estimation and accuracy improvement of computer simulations of computer aided engineering (CAE) models based on prediction and correction state estimation techniques and sensing. The aim is to simulate the
Externí odkaz:
https://doaj.org/article/517e0c797aa549f7a1f35665aac23a13
Autor:
Carlos Cuesta-Mateos, Patricia Fuentes, Alexandra Schrader, Raquel Juárez-Sánchez, Javier Loscertales, Tamara Mateu-Albero, Lorena Vega-Piris, Marina Espartero-Santos, Ana Marcos-Jimenez, Blanca Andrea Sánchez-López, Yaiza Pérez-García, Dennis Jungherz, Sebastian Oberbeck, Linus Wahnschaffe, Anna Kreutzman, Emma I. Andersson, Satu Mustjoki, Edgar Faber, Ana Urzainqui, Manuel Fresno, Kostantino Stamatakis, Arantzazu Alfranca, Fernando Terrón, Marco Herling, María Luisa Toribio, Cecilia Muñoz-Calleja
Publikováno v:
Biomarker Research, Vol 8, Iss 1, Pp 1-17 (2020)
Abstract T-cell prolymphocytic leukemia (T-PLL) is a poor prognostic disease with very limited options of efficient therapies. Most patients are refractory to chemotherapies and despite high response rates after alemtuzumab, virtually all patients re
Externí odkaz:
https://doaj.org/article/de532df98e854abe8a204e17060b7cf5
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
According to the classical paradigm, CCR7 is a homing chemokine receptor that grants normal lymphocytes access to secondary lymphoid tissues such as lymph nodes or spleen. As such, in most lymphoproliferative disorders, CCR7 expression correlates wit
Externí odkaz:
https://doaj.org/article/1995b41807c148b2a33037a8c0db87ff
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
The lymph node (LN) is an essential tissue for achieving effective immune responses but it is also critical in the pathogenesis of chronic lymphocytic leukemia (CLL). Within the multitude of signaling pathways aberrantly regulated in CLL the homeosta
Externí odkaz:
https://doaj.org/article/291da3b582e84f86b2dc368409fc4106
Autor:
Carlos Cuesta-Mateos, Raquel Juárez-Sánchez, Tamara Mateu-Albero, Javier Loscertales, Wim Mol, Fernando Terrón, Cecilia Muñoz-Calleja
Publikováno v:
mAbs, Vol 13, Iss 1 (2021)
Lymph node (LN) is a key tissue in the pathophysiology of mature blood cancers, especially for chronic lymphocytic leukemia (CLL). Within the multiple de-regulated pathways affecting CLL homeostasis, the CC-chemokine receptor 7 (CCR7) grants homing o
Externí odkaz:
https://doaj.org/article/6bb548f0068d42ef8740d2466d9dbdd9
Autor:
Esther Ortega-Díaz, Jonatan García-Campos, José María Rico-Gomis, Carlos Cuesta-Moreno, Antonio Palazón-Bru, Gabriel Estañ-Cerezo, José Antonio Piqueras-Rodríguez, Jesús Rodríguez-Marín
Publikováno v:
PeerJ, Vol 8, p e10212 (2020)
Background A few papers studying healthy, first-degree relatives of people with borderline personality disorder (BPD) have found that this group presents attention and memory problems. However, current research has not analyzed their social cognition
Externí odkaz:
https://doaj.org/article/e6e48fd2e6474aaa90228a9eeb718adf
Autor:
Beatriz Colom-Fernández, Anna Kreutzman, Ana Marcos-Jiménez, Valentín García-Gutiérrez, Carlos Cuesta-Mateos, Itxaso Portero-Sainz, Yaiza Pérez-García, Luis Felipe Casado, Fermín Sánchez-Guijo, Joaquín Martínez-López, Rosa M. Ayala, Concha Boqué, Blanca Xicoy, Isabel Montero, César Soto, Raquel Paz, Gabriela Silva, Lorena Vega-Piris, Juan Luis Steegmann, Cecilia Muñoz-Calleja
Publikováno v:
Frontiers in Pharmacology, Vol 10 (2019)
Introduction: Dasatinib is a dual SRC/ABL tyrosine kinase inhibitor used to treat chronic myeloid leukemia (CML) that is known to have unique immunomodulatory effects. In particular, dasatinib intake typically causes lymphocytosis, which has been lin
Externí odkaz:
https://doaj.org/article/8076d19c9d6e4febaa5ad4e8c9a321dd
Publikováno v:
Frontiers in Immunology, Vol 8 (2018)
Today, monoclonal antibodies (mAbs) are a widespread and necessary tool for biomedical science. In the hematological cancer field, since rituximab became the first mAb approved by the Food and Drug Administration for the treatment of B-cell malignanc
Externí odkaz:
https://doaj.org/article/2dc722a1ea5e4e479626074372fc58f4
Publikováno v:
Plastic and Reconstructive Surgery, Global Open, Vol 5, Iss 12, p e1619 (2017)
Externí odkaz:
https://doaj.org/article/66cf474f933d424b902252e76b13e644
Autor:
José Carles, Carlos Cuesta
Publikováno v:
Executory Contracts in Insolvency Law ISBN: 9781803923420
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fa2f669e3ddf820cfe3be3a9c48a1908
https://doi.org/10.4337/9781803923420.00038
https://doi.org/10.4337/9781803923420.00038
